Hawman, David W. http://orcid.org/0000-0001-8233-8176
Leventhal, Shanna S.
Meade-White, Kimberly
Khandhar, Amit
Murray, Justin
Lovaglio, Jamie http://orcid.org/0000-0002-7567-446X
Shaia, Carl http://orcid.org/0000-0001-8907-8821
Saturday, Greg http://orcid.org/0000-0002-0803-6177
Hinkley, Troy
Erasmus, Jesse http://orcid.org/0000-0003-1612-2697
Feldmann, Heinz http://orcid.org/0000-0001-9448-8227
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (N/A, N/A)
Department of Defense
Article History
Received: 4 January 2024
Accepted: 7 May 2024
First Online: 20 May 2024
Competing interests
: J.E. has equity interest in HDT Bio and is a co-inventor on U.S. patent application no. 62/993,307 “Compositions and methods for delivery of RNA” pertaining to formulations for RNA delivery. D.W.H., J.E., and H.F. are inventors on U.S. patent application number 63/365,015 “Replicating RNA vaccine for Crimean-Congo hemorrhagic fever virus” regarding the repRNA for use against CCHFV.